C

China Baoan Group Co Ltd
SZSE:000009

Watchlist Manager
China Baoan Group Co Ltd
SZSE:000009
Watchlist
Price: 9.5 CNY -0.21% Market Closed
Market Cap: 24.5B CNY
Have any thoughts about
China Baoan Group Co Ltd?
Write Note

China Baoan Group Co Ltd
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

China Baoan Group Co Ltd
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
C
China Baoan Group Co Ltd
SZSE:000009
Note Receivable
ÂĄ14.9m
CAGR 3-Years
-64%
CAGR 5-Years
-48%
CAGR 10-Years
N/A
CITIC Ltd
HKEX:267
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fosun International Ltd
HKEX:656
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yueda Investment Co Ltd
SSE:600805
Note Receivable
ÂĄ9.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhe Jiang Jian Feng Group Co Ltd
SSE:600668
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Beijing Aerospace Changfeng Co Ltd
SSE:600855
Note Receivable
ÂĄ25.3m
CAGR 3-Years
-25%
CAGR 5-Years
-21%
CAGR 10-Years
-20%
No Stocks Found

China Baoan Group Co Ltd
Glance View

Market Cap
24.5B CNY
Industry
Industrial Conglomerates

China Baoan Group Co., Ltd., established in 1983, has evolved into a dynamic conglomerate that seamlessly merges tradition with innovation. Rooted initially in the real estate sector, the company expanded its horizons over the decades, venturing into a diverse array of industries. Today, its portfolio encompasses pharmaceuticals, new materials, and high-technology ventures, each segment contributing its distinct thread to the company's rich tapestry. Real estate remains a foundational pillar of its operations, providing a steady revenue base through the development and management of commercial and residential properties across China. With strategic diversification, the company has maneuvered through economic cycles, skillfully leveraging its core competencies to unlock new growth avenues. Beyond the bricks and mortar, China Baoan's venture into pharmaceuticals and new materials signifies its adaptability and pursuit of future-ready sectors. In the pharmaceutical realm, it channels resources into research and development, producing advanced medical solutions and healthcare products that meet the growing demands of the domestic market. Meanwhile, its development of new materials, particularly in lithium-ion batteries and related technologies, aligns with global transitions towards sustainable energy. This sector not only complements its real estate development by aiding innovation in construction materials but also taps into the burgeoning electric vehicle industry, thus opening new revenue streams. Through this intricate blend of legacy and futurism, China Baoan Group crafts its narrative as a versatile power in China's ever-evolving economic landscape, continually seeking opportunities to enhance its footprint both domestically and abroad.

Intrinsic Value
6.01 CNY
Overvaluation 37%
Intrinsic Value
Price
C

See Also

What is China Baoan Group Co Ltd's Note Receivable?
Note Receivable
14.9m CNY

Based on the financial report for Sep 30, 2024, China Baoan Group Co Ltd's Note Receivable amounts to 14.9m CNY.

What is China Baoan Group Co Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
-48%

Over the last year, the Note Receivable growth was -47%. The average annual Note Receivable growth rates for China Baoan Group Co Ltd have been -64% over the past three years , -48% over the past five years .

Back to Top